Results 101 to 110 of about 21,587 (248)
Food Science &Nutrition, Volume 13, Issue 12, December 2025.This study identified the core food‐herb formula “Astragali Radix‐Poria‐Rheum (Ast‐Por‐Rhe)” for Diabetic Kidney Disease (DKD) through data mining of clinical prescriptions. Integrated network pharmacology and in vivo validation revealed that this formula ameliorates renal injury and insulin resistance in DKD rats by activating the IRS1/PI3K/AKT ...
Meizi Wang +8 more
wiley +1 more source
Alimentary Pharmacology &Therapeutics, Volume 62, Issue 11-12, Page 1108-1124, December 2025.Rates of inpatient mortality and complication rates in cirrhosis remain high. With regard to inpatient outcomes, cirrhosis is falling behind other chronic health conditions. ABSTRACT Background The aetiologies, complications and overall burden of cirrhosis have undergone changes in recent years.
Julian Pohl +9 more
wiley +1 more source
Zdravniški Vestnik, 2001 Background. Hepatorenal syndrome (HRS) is acommon complication of advanced hepatic disease characterizedby marked abnormalities in arterial circulation and byrenal failure. An extreme arteriolar vasodilatation located inthe splanchnic circulation results
Matjaž Hafner
doaj
Accumulation of symetric dimethylarginine in hepatorenal syndrome. [PDF]
, 2006 In patients with cirrhosis, nitric oxide (NO), asymmetric dimethylarginine (ADMA), and possibly symmetric dimethylarginine (SDMA) have been linked to the severity of the disease.
Lluch García, Paloma +7 more
core +1 more source
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation
Alimentary Pharmacology &Therapeutics, Volume 62, Issue 11-12, Page 1202-1211, December 2025.The novel classification of acute and non‐acute decompensation provides prognostic information, but the role of hospitalisation status should be reconsidered. ABSTRACT Background A more granular understanding of hepatic decompensation in cirrhosis has led to the classification of acute decompensation (AD) and non‐acute decompensation (NAD).
Lucie Simonis +19 more
wiley +1 more source
Journal of Cellular and Molecular Medicine, Volume 29, Issue 23, December 2025.ABSTRACT Liver disease is a leading cause of death worldwide. Nucleated red blood cells (NRBCs) are associated with high mortality and poor outcomes in patients with severe illnesses. However, the relationship between NRBCs and severe liver disease remains unclear. Potential confounding effects were managed using propensity score matching.
Yuanyuan Zhu +4 more
wiley +1 more source
The Egyptian Journal of Radiology and Nuclear Medicine, 2014 Objectives: The aim of this work was to study the renal hemodynamic changes which occur with liver cirrhosis using diffusion weighted magnetic resonance imaging (DW-MRI) and renal color duplex Doppler ultrasound.
Mohamed M Hefeda +2 more
doaj +1 more source
Principles of portal hypertension treatment at patients with liver cirrhosis
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2012 The aim of review. To describe modern principles of portal hypertension treatment in patients with liver cirrhosis (LC).Original positions. One of the most significant LC complications is portal hypertension - acute bleeding from varicose veins (VV) of ...
Ye. A. Fedosina +2 more
doaj
Liver International, Volume 45, Issue 12, December 2025.ABSTRACT Background and Aims Albumin is well established for some acute indications in decompensated cirrhosis, but its long‐term use remains controversial. The ALBA study explored expert clinical perspectives, barriers, and current practices regarding long‐term albumin therapy in Spain.
Jose Ignacio Fortea +4 more
wiley +1 more source